Neale T. Hanke, Ph.D.
Affiliations: | 2012 | Cancer Biology | University of Arizona, Tucson, AZ |
Area:
Oncology, ImmunologyGoogle:
"Neale Hanke"Parents
Sign in to add mentor| Emmanuel Katsanis | grad student | 2012 | University of Arizona | |
| (Molecular regulation of the tumor killing activity of dendritic cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hanke NT, Imler E, Marron MT, et al. (2018) Characterization of carfilzomib-resistant non-small cell lung cancer cell lines. Journal of Cancer Research and Clinical Oncology |
| Akhenblit PJ, Hanke NT, Gill A, et al. (2016) Assessing Metabolic Changes in Response to mTOR Inhibition in a Mantle Cell Lymphoma Xenograft Model Using AcidoCEST MRI. Molecular Imaging. 15 |
| Hanke NT, Garland LL, Baker AF. (2015) Carfilzomib combined with suberanilohydroxamic acid (SAHA) synergistically promotes endoplasmic reticulum stress in non-small cell lung cancer cell lines. Journal of Cancer Research and Clinical Oncology |
| Malm SW, Hanke NT, Gill A, et al. (2015) The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines. Journal of Experimental & Clinical Cancer Research : Cr. 34: 31 |
| Baker AF, Hanke NT, Sands BJ, et al. (2014) Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models. Journal of Experimental & Clinical Cancer Research : Cr. 33: 111 |
| Baker AF, Hanke NT, Sands BJ, et al. (2014) Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models. Journal of Experimental & Clinical Cancer Research : Cr. 33: 111 |
| Hanke NT, LaCasse CJ, Larmonier CB, et al. (2014) PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15. European Journal of Immunology. 44: 2489-99 |
| Alizadeh D, Trad M, Hanke NT, et al. (2014) Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer. Cancer Research. 74: 104-18 |
| Hanke N, Alizadeh D, Katsanis E, et al. (2013) Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy. Critical Reviews in Immunology. 33: 1-21 |
| Centuori SM, Trad M, LaCasse CJ, et al. (2012) Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells. Journal of Leukocyte Biology. 92: 987-97 |